Results 81 to 90 of about 416,692 (196)

Oral cholera vaccine

, 2013
The present invention provides s DNA plasmid pVAX1 comprising coding sequences of the Vibrio cholerae genes ctxB, optionally encapsulated in alginate or cellulose acetate phthalate microspheres.
Shamsudin, Mariana Nor, Rosli, Rozita, Abdullah, Syahrilnizam, Hanafi, Aimi Melati, Nograles, Nadine   +4 more
core   +1 more source

Hog cholera and hog cholera vaccine

, 1908
This archival publication may not reflect current scientific knowledge or recommendations. Current information available from University of Minnesota Agricultural Experiment Station: http://www.maes.umn.edu/Reynolds, M.
University of Minnesota. Veterinary Division, Reynolds, M. H.   +1 more
core  

A study of typhoid fever in five asian countries: disease burden and implications for controls

Bulletin of the World Health Organization, 2008
OBJECTIVE: To inform policy-makers about introduction of preventive interventions against typhoid, including vaccination. METHODS: A population-based prospective surveillance design was used.
R Leon Ochiai, Camilo J Acosta, M Carolina Danovaro-Holliday, Dong Baiqing, Sujit K Bhattacharya, Magdarina D Agtini, Zulfiqar A Bhutta, Do Gia Canh, Mohammad Ali, Seonghye Shin, John Wain, Anne-Laure Page, M John Albert, Jeremy Farrar, Remon Abu-Elyazeed, Tikki Pang, Claudia M Galindo, Lorenz von Seidlein, John D Clemens   +18 more
doaj  

A Metapopulation Model for Cholera with Variable Media Efficacy and Imperfect Vaccine

Journal of Mathematical Sciences and Modelling
In this paper, a metapopulation model has been developed and analysed to describe the transmission dynamics of cholera between two communities linked by migration, in the presence of an imperfect vaccine and a varying media awareness impact.
George Lawı, Phoebe Amadi, Job Bonyo
doaj   +1 more source

Ending cholera : a global roadmap to 2030 [PDF]

Ending Cholera\u2014A Global Roadmap to 2030 operationalises the new global strategy for cholera control at the country level and provides a concrete path toward a world in which cholera is no longer a threat to public health.

core  

Flow diagram of mHealth vaccine registration for a reactive oral cholera vaccine campaign in rural Haiti, April–June 2012.

, 2014
Flow diagram of mHealth vaccine registration for a reactive oral cholera vaccine campaign in rural Haiti, April–June 2012.
Max Raymond (488286), Jonathan S. Lascher (606682), Dana R. Thomson (496122), Louise C. Ivers (219095), Jessica E. Teng (557895)   +4 more
core   +1 more source

Attitude towards cholera vaccination and its related factors in Jordan amid the 2022 Middle East outbreak

BMC Public Health
Background An outbreak of cholera was reported in the Middle East by the second half of 2022. Raising public awareness and vaccination against cholera represent critical factors in the preventive efforts.
Malik Sallam, Rabaa Y. Athamneh, Rawan Alkhazaleh, Lana Alzayadneh, Laila Jaradat, Tala Majali, Sarah Obeidat, Aseel Shhab, Souheil Hallit, Muna Barakat, Azmi Mahafzah   +10 more
doaj   +1 more source

Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

, 2019
Current oral cholera vaccines induce lower protective efficacy and shorter duration of protection against cholera than wild-type infection provides, and this difference is most pronounced in young children.
Leung, Daniel, Riyadh, M. Asrafuzzaman, Calderwood, Stephen, Alam, Mohammad Murshid, LaRocque, Regina, Khan, Ashraful Islam, Rahman, Mohammad Arif, Qadri, Firdausi, Mohasin, M., Ryan, Edward, Uddin, Taher, Patel, Sweta, Charles, Richelle, Harris, Jason, Saha, Amit, Khanam, Farhana, Chowdhury, Fahima, Aktar, Amena   +17 more
core   +1 more source

Oral killed cholera vaccines for preventing cholera

Cochrane Database of Systematic Reviews
Cholera causes acute watery diarrhoea and death if not properly treated. Outbreaks occur in areas with poor sanitation, including refugee camps. Several vaccines have been developed and tested over the last 50 years. This is an update of a Cochrane review, originally published in 1998, which explored the effects of all vaccines for preventing cholera ...
Saif-Ur-Rahman, K.M., Mamun, R., Hasan, M., Meiring, J.E., Khan, M.A.   +4 more
openaire   +5 more sources

Immune Responses to the O-Specific Polysaccharide Antigen in Children Who Received a Killed Oral Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

, 2019
Current oral cholera vaccines induce lower levels of protective efficacy and shorter durations of protection in young children than in adults. Immunity against cholera is serogroup specific, and immune responses to Vibrio cholerae lipopolysaccharide (LPS)
Xu, Peng, Wu-Freeman, Ying, Kováč, Pavol, Harris, Jason B., Alam, Mohammad Murshid, Rahman, Mohammad Arif, Eckhoff, Grace, Calderwood, Stephen B., Leung, Daniel T., Qadri, Firdausi, Ryan, Edward T., Charles, Richelle C., Khan, Ashraf I., Johnson, Russell A., Uddin, Taher, Yu, Yanan, Bufano, Meagan Kelly, Saha, Amit, Khanam, Farhana, Chowdhury, Fahima, LaRocque, Regina C., Aktar, Amena, Sultana, Tania   +22 more
core   +1 more source